配送の追跡:ナノキャリアの新技術(Tracking delivery: new technology for nanocarriers)

ad

2025-01-14 ミュンヘン大学(LMU)

LMUミュンヘンを中心とする研究チームは、「SCP-Nano」と呼ばれる技術を開発し、ナノキャリアが体内でどのように分布し、細胞と相互作用するかを単一細胞レベルで追跡することに成功しました。この技術は、光学的組織透明化、ライトシート顕微鏡、AI解析を組み合わせ、ナノキャリアのターゲット精度や副作用リスクを評価可能にします。mRNAワクチンや遺伝子治療などの治療法をより安全で効果的にすることが期待され、精密医療への貢献が見込まれます。

<関連情報>

ディープラーニングでマウスの体全体を単一細胞解像度でナノキャリアイメージング Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning

Jie Luo,Muge Molbay,Ying Chen,Izabela Horvath,Karoline Kadletz,Benjamin Kick,Shan Zhao,Rami Al-Maskari,Inderjeet Singh,Mayar Ali,Harsharan Singh Bhatia,David-Paul Minde,Moritz Negwer,Luciano Hoeher,Gian Marco Calandra,Bernhard Groschup,Jinpeng Su,Ceren Kimna,Zhouyi Rong,Nikolas Galensowske,Mihail Ivilinov Todorov,Denise Jeridi,Tzu-Lun Ohn,Stefan Roth,… Ali Erturk
Nature Biotechnology  Published:14 January 2025
DOI:https://doi.org/10.1038/s41587-024-02528-1

配送の追跡:ナノキャリアの新技術(Tracking delivery: new technology for nanocarriers)

Abstract

Efficient and accurate nanocarrier development for targeted drug delivery is hindered by a lack of methods to analyze its cell-level biodistribution across whole organisms. Here we present Single Cell Precision Nanocarrier Identification (SCP-Nano), an integrated experimental and deep learning pipeline to comprehensively quantify the targeting of nanocarriers throughout the whole mouse body at single-cell resolution. SCP-Nano reveals the tissue distribution patterns of lipid nanoparticles (LNPs) after different injection routes at doses as low as 0.0005 mg kg-1—far below the detection limits of conventional whole body imaging techniques. We demonstrate that intramuscularly injected LNPs carrying SARS-CoV-2 spike mRNA reach heart tissue, leading to proteome changes, suggesting immune activation and blood vessel damage. SCP-Nano generalizes to various types of nanocarriers, including liposomes, polyplexes, DNA origami and adeno-associated viruses (AAVs), revealing that an AAV2 variant transduces adipocytes throughout the body. SCP-Nano enables comprehensive three-dimensional mapping of nanocarrier distribution throughout mouse bodies with high sensitivity and should accelerate the development of precise and safe nanocarrier-based therapeutics.

生物工学一般
ad
ad
Follow
ad
タイトルとURLをコピーしました